|
|
|
Volumn 26, Issue , 1996, Pages 86-99
|
|
Clinical development plan: dehydroepiandrosterone (DHEA).
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
PRASTERONE;
AGED;
ANIMAL;
ARTICLE;
DRUG APPROVAL;
EXPERIMENTAL NEOPLASM;
FEMALE;
HUMAN;
MALE;
METHODOLOGY;
MIDDLE AGED;
NEOPLASM;
PHASE 2 CLINICAL TRIAL;
RAT;
TOXICITY TESTING;
AGED;
ANIMALS;
ANTICARCINOGENIC AGENTS;
CLINICAL TRIALS, PHASE II;
DEHYDROEPIANDROSTERONE;
DRUG APPROVAL;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
NEOPLASMS;
NEOPLASMS, EXPERIMENTAL;
RATS;
RESEARCH DESIGN;
TOXICITY TESTS;
|
|
EID: 0030325046
PISSN: 07331959
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (3)
|
|
References (0)
|